Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam in IBS-diarrhea
NCT02111603Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2014
- Primary completion
- Aug 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colesevelam in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Mayo Clinic. Started Apr 2014; status: completed.
02
Drugs
colesevelam
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02111603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111603.